IntriCon Co. (NASDAQ:IIN) has received a consensus broker rating score of 2.00 (Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation.

Brokerages have set a twelve-month consensus target price of $11.00 for the company and are predicting that the company will post ($0.04) EPS for the current quarter, according to Zacks. Zacks has also assigned IntriCon an industry rank of 108 out of 265 based on the ratings given to its competitors.

Several research firms have weighed in on IIN. ValuEngine upgraded shares of IntriCon from a “sell” rating to a “hold” rating in a report on Friday. Dougherty & Co upped their target price on shares of IntriCon from $10.00 to $11.00 and gave the stock a “buy” rating in a research note on Friday, February 17th. Finally, Zacks Investment Research lowered shares of IntriCon from a “hold” rating to a “sell” rating in a research note on Friday, February 17th.

COPYRIGHT VIOLATION WARNING: “Zacks: Analysts Set $11.00 Price Target for IntriCon Co. (IIN)” was first published by Financial Market News and is the sole property of of Financial Market News. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.financial-market-news.com/2017/06/03/zacks-analysts-set-11-00-price-target-for-intricon-co-iin.html.

Several hedge funds have recently bought and sold shares of IIN. Heartland Advisors Inc. raised its stake in IntriCon by 46.3% in the first quarter. Heartland Advisors Inc. now owns 804,877 shares of the technology company’s stock valued at $7,324,000 after buying an additional 254,877 shares during the last quarter. Renaissance Technologies LLC raised its position in IntriCon by 6.0% in the first quarter. Renaissance Technologies LLC now owns 184,899 shares of the technology company’s stock valued at $1,683,000 after buying an additional 10,499 shares during the last quarter. Pacific Alternative Asset Management Company LLC bought a new position in IntriCon during the third quarter valued at $630,000. Emancipation Management LLC raised its position in IntriCon by 26.8% in the fourth quarter. Emancipation Management LLC now owns 56,350 shares of the technology company’s stock valued at $388,000 after buying an additional 11,900 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in IntriCon by 5.8% in the first quarter. Vanguard Group Inc. now owns 20,613 shares of the technology company’s stock valued at $188,000 after buying an additional 1,135 shares during the last quarter. Hedge funds and other institutional investors own 26.60% of the company’s stock.

IntriCon (NASDAQ:IIN) remained flat at $8.10 on Wednesday. 84 shares of the company’s stock were exchanged. The firm’s market capitalization is $55.43 million. The company has a 50-day moving average of $8.61 and a 200-day moving average of $7.68. IntriCon has a one year low of $4.12 and a one year high of $9.65.

IntriCon (NASDAQ:IIN) last released its quarterly earnings data on Thursday, April 27th. The technology company reported ($0.02) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.07) by $0.05. IntriCon had a negative net margin of 2.82% and a negative return on equity of 7.43%. The firm had revenue of $20.09 million for the quarter, compared to the consensus estimate of $18.48 million. On average, equities research analysts forecast that IntriCon will post $0.18 EPS for the current year.

IntriCon Company Profile

IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.

Get a free copy of the Zacks research report on IntriCon (IIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for IntriCon Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon Co. and related companies with MarketBeat.com's FREE daily email newsletter.